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Research letter
Novel autosomal dominant mutation in loricrin
presenting as prominent ichthyosis
DOI: 10.1111/bjd.13895
DEAR EDITOR, Loricrin keratoderma (syn. Camisa syndrome,
OMIM 604117) is a rare autosomal dominant genodermatosis
characterized by palmoplantar keratoderma and ichthyosis.1,2 It
is caused by mutations in loricrin, a small basic protein synthe-
sized in the upper granular layer, which becomes a major con-
stituent of the cornified cell envelope.3 Seven distinct mutations
in loricrin have been reported in 15 unrelated pedigrees to
date.4–6 We report a multi-generation family with prominent
ichthyosis and palmoplantar involvement due to a novel muta-
tion in loricrin.
The proband was a 14-year-old boy who presented with
generalized dryness and scaling affecting his trunk and all four
limbs, previously thought to be ichthyosis vulgaris, which was
reported from early childhood (Fig. 1a). Clinical examination
revealed widespread, prominent ichthyosis and mild diffuse
transgredient hyperkeratosis of palms and soles. There was no
evidence of atopic dermatitis or keratosis pilaris. His mother
and eight other family members were similarly affected
(Fig. 1b). Subsequently, a further child was born with a collo-
dion membrane followed by generalized ichthyosis.
Biopsies of affected skin were processed for light and elec-
tron microscopy by standard methods (upper back of the pro-
band’s mother) or for electron microscopy only (affected acral
skin from the proband’s grandfather).7 Following informed
consent, genomic DNA was extracted from blood or saliva
samples from 10 affected and unaffected family members
(Fig. 1a). A whole exome sequencing approach was taken to
analyse the proband’s DNA (Methods S1; see Supporting
Information).
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Fig 1. (a) Pedigree of family with loricrin keratoderma. Filled symbols represent affected individuals. Whole exome sequencing was performed on
one affected family member. *marks individuals who were screened for loricrin mutation by Sanger sequencing. (b–d) Clinical pictures of (b) the
proband: ichthyosis of upper back with brawny appearance and knuckle pads; (c) proband’s mother: transgredient hyperkeratosis of palms and
soles; (d) proband’s grandfather: widespread ichthyosis of forearm and trunk.
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Light microscopy of skin from the proband’s mother
showed mild hyperkeratosis, a normal granular layer and no
significant parakeratosis (Fig. 2a). Electron microscopy of (i)
affected acral skin demonstrated mild intracellular oedema,
abundant keratohyaline granules in upper layers, with
desmosomes and keratin filaments appearing intact and of
(ii) affected upper back skin, vacuolar changes and disrup-
tion of suprabasal keratinocytes (Fig. 3). Whole exome
sequencing directed at relevant epidermal genes revealed a
novel heterozygous duplication mutation in the loricrin gene
in exon 2 (designated c.806dupG), with an insertion of a
single base pair resulting in a frameshift leading to a delayed
termination codon and elongation of the protein by 22
amino acids (Fig. 2d). The mutation was confirmed by
Sanger sequencing (Methods S2; see Supporting Information)
and was present in affected individuals but was not in
unaffected family members (Figs 1a, 2b,c). This mutation is
not on the dbSNP database or NHLBI Exome Variant Server
(http://evs.gs.washington.edu/EVS/).
Six different heterozygous insertion mutations in loricrin
in 14 unrelated pedigrees have previously been
reported and one heterozygous deletion in a further pedi-
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Fig 2. (a) A biopsy from the proband’s mother’s skin showing mild hyperkeratosis, a normal granular layer and no significant parakeratosis
(original magnification 9 20). (b–d) Mutation analysis. (b) Normal loricrin sequence in exon 2, showing nucleotides 799–813 (codons
267–271). (c) The equivalent region as in (b) from the proband showing the heterozygous mutation c.806dupG, leading to a delayed
termination codon and a mutant protein 22 amino acids longer than wild-type. (d) Nucleotide sequence at the 50 end of loricrin. The
inserted G nucleotide is in bold and indicated with an arrow. The predicted amino acid sequences of the wild-type and mutant (underlined)
alleles are shown.
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gree2,4–6,8,9,11–13 (see Supporting Information; Table S1).
All six insertion mutations are single base-pair insertions
leading to delayed termination codons with the most
frequent mutation 730insG being present in eight of the
14 published families.2,4,8–13 This region of the loricrin
gene is thought to be a mutation hotspot because of the
presence of six consecutive guanine nucleotides.12All
single-base-pair insertion and deletion mutations lead to a
frameshift and delayed termination, thus elongating the
protein by 22 amino acids and changing the Gly-Lys-rich
domain into an Arg-Leu-rich terminal domain,2 except for
two pedigrees of Brazilian origin, where the new protein
is 25 amino acids longer than wild-type protein.5 The
mechanism of action of these mutations is thought to
relate to preferential localization of mutant loricrin in the
nucleus due to the formation of nuclear localization
sequences within the arginine-rich mutant loricrin.14 It has
been suggested that the abnormal nuclear protein may dis-
rupt the apoptotic process in terminal differentiation of
keratinocytes in mouse models, thus supporting the
hypothesis that the phenotype of loricrin keratoderma is
caused by the synthesis of mutant loricrin rather than by
the lack of wild-type loricrin.14,15 No clear genotype-phe-
notype associations for pedigrees with specific mutations
have currently been identified.4,5,13
The phenotype of loricrin keratoderma is heterogeneous.
The common clinical features in both the 15 previously
reported pedigrees and our new pedigree are palmoplantar
keratoderma, usually of a honeycomb pattern, and general-
ized ichthyosis. Other features, including knuckle pads,
pseudoainhum/hyperconstricting bands with autoamputa-
tion of digits and collodion babies, are variably reported.
Previously, Gedicke et al.13 have suggested that the term
‘mutilating keratoderma with ichthyosis’ is not entirely
suitable, due to the variation in phenotypes previously
reported. Similarly, given the prominence of generalized
ichthyosis with lesser palmoplantar involvement in this
pedigree, and the presence of generalized ichthyosis in all
previously reported pedigrees, we suggest that the condi-
tion could be described as loricrin ichthyosis rather than
loricrin keratoderma.
Acknowledgments
We would like to thank the patients, their family members
and control subjects for their cooperation in this study.
E . POHL ER1
F . CUNN INGHAM2
A. SAND I L AND S1
C . COL E3
S . D IGBY4
J .R . MCMIL LAN5
S . AR I S TOD EMOU5
J .A . MCGRATH6
F . J .D . SM I TH1
W.H. I . MCLEAN1
C .S . MUNRO7
M. ZAM IR I 2 , 7
1Centre for Dermatology and Genetic
Medicine, Colleges of Life Sciences and
Medicine, Dentistry and Nursing and
3Division of Computational Biology, College
of Life Sciences, University of Dundee, U.K.
2Department of Dermatology, University
Hospital Crosshouse, Kilmarnock Road,
Kilmarnock KA2 0BE, U.K.
4Department of Pathology and 7Alan Lyell
Centre for Dermatology, Southern General
Hospital, Glasgow, U.K.
5EB Laboratory, Viapath LLP, St Thomas’
Hospital, London Group, King’s College
London (Guy’s Campus), U.K.
6Department of Cell Pathology, St John’s
(a)
(b)
(c)
Fig 3. Semithin sections and ultrastructural images. In semithin
sections (a) there was epidermal acanthosis and compact
hyperkeratosis with a pattern of diffuse vacuolar change. These
vacuoles (small arrows) were predominantly observed in the
suprabasal keratinocyte layers. Suprabasal layer keratinocytes also
showed focal cytolytic changes and some cells appeared necrotic. (b)
Ultrastructurally there was disruption to the normal keratin filament
network within suprabasal keratinocytes concurrent with the presence
of peri-nuclear, membrane-bound vacuoles (V), some containing
granular material. At higher magnification (c), keratin filament
networks (K) were disturbed or showed some clumping particularly
around the nucleus (N). Desmosome connections between
keratinocytes mostly appeared normal, although there were small
detached desmosomes (D) with disrupted keratin filament (K)
association in some areas together with a slight widening of
intercellular spaces between adjacent keratinocytes and some granular
debris (G) present within the intercellular spaces. Scale bars 50 lm
(a), 5 lm (b) and 500 nm (c).
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